BioCardia, Inc. (BCDA) vs Chemomab Therapeutics Ltd. Sponsored ADR (CMMB)

BioCardia, Inc. and Chemomab Therapeutics Ltd. Sponsored ADR are both Biotechnology companies. BioCardia, Inc. and Chemomab Therapeutics Ltd. Sponsored ADR are of similar size ($16.2M and $16.0M). Across the 10 metrics below, Chemomab Therapeutics Ltd. Sponsored ADR leads on 6 and BioCardia, Inc. on 4.

Valuation

Metric BCDA CMMB Biotechnology median
P/E n/m n/m 7.88
P/S 29.67 n/m 11.47
P/B 4.70 1.99 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 23.31 n/m 10.73
Earnings yield (60.95%) (37.06%) (28.84%)
Free cash flow yield (59.63%) (210.63%) (23.03%)

Profitability

Metric BCDA CMMB Biotechnology median
Gross margin 100.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (1,803.19%) (82.17%) (57.72%)
Return on assets (214.47%) (70.70%) (49.22%)
Return on invested capital 0.00% (247.40%) 0.00%

Growth

Metric BCDA CMMB Biotechnology median
Revenue growth (TTM) 0.71% — 5.64%
EPS growth (last fiscal year) 57.59% 58.14% —
Revenue growth, 5-year CAGR 26.89% — 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric BCDA CMMB Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.09 6.41 4.73
Net debt to EBITDA 0.30 1.09 0.96

Dividend

Metric BCDA CMMB Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BCDA CMMB Biotechnology median
Market cap 16.20m 15.95m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack